Visiongain has published a new report entitled Meningococcal Vaccines Market Report 2024-2034: Forecasts by Type (Polysaccharide Vaccines, Conjugate Vaccines, Combination Vaccines, Men B Vaccines), by ...

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) today announced that the U.S. Food and Drug Administration (FDA) accepted for review a Biologics License Application (BLA) for its investigational ...

Oct 20 (Reuters) - The U.S. Food and Drug Administration (FDA) has approved Pfizer's (PFE.N), opens new tab vaccine Penbraya, making it the first shot to protect against five groups of a deadly ...

The FDA has approved a new Pfizer meningococcal vaccine whose simpler dosing schedule is expected to make it easier for children and young adults to get fully vaccinated to protect against a rare ...

While Pfizer’s approval has won Penbraya some time to its own on the market, GSK is close behind with its own pentavalent competitor. (VIEW press/Corbis News/Getty Images) In the race to secure U.S.

Dr. Samba O. Sow, Director General of CVD-Mali, has led efforts to eradicate meningococcal disease in the African Meningitis Belt for more than a decade. University of Maryland School of Medicine ...

GSK's pentavalent vaccine offers protection against the five most common serogroups that cause invasive meningococcal disease. (iStock / Getty Images Plus) Pfizer’s two-year run with the only 5-in-1 ...

University of Maryland School of Medicine (UMSOM) researchers helped conduct an important new global health study that found a vaccine that protects against five strains of meningitis prevalent in sub ...